(DNLI) – Mergers and Acquisitions
-
Denali Therapeutics (DNLI) Reports Positive Clinical Results from LRRK2 Inhibitor Program for Parkinson’s Disease
-
Denali Therapeutics (DNLI) Announces Early Exercise of Its Option to Acquire F-star Gamma
Back to DNLI Stock Lookup